BLUE BELL, Pa., March 17, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) today reported financial results for the fourth quarter and year ended December 31, 2010.
Total revenue was $2.4 million and $6.1 million for the quarter and year ended December 31, 2010, compared to $2.6 mi